User Manual
Table Of Contents
- 1. General description
- 2. Intended use and targeted population
- 3. Contraindications and adverse events
- 4. Warnings
- 5. Clinical studies
- 6. Patient selection and treatment
- 7. Patient counseling information
- 8. Declaration of conformity
- 9. Physician guidelines
- 10. Patient information
- 11. How supplied
- 12. Implant procedure
- 13. Pacemaker interrogation and upgrade
- 14. Special modes
- 15. Functions and parameters
- 16. Patient follow-up
- 17. Standby mode
- 18. Medical follow-up
- 19. Physical characteristics
- 20. Electrical characteristics
- 21. Programmable parameters
- 22. Non-programmable parameters
- 23. Warranty
- 24. Explanation of symbols
20. ELECTRICAL CHARACTERISTICS
Input impedance
Unipolar ≥ 40 kΩ
Bipolar ≥ 40 kΩ
Pulse form
CURRENT DRAIN AT BEGINNING OF SERVICE
Battery condition BOS=3.20 V without Remote monitoring
Battery condition BOS=3.10 V with Remote monitoring
For the DR model, the current drain at the beginning of service is as follows:
Shipment conditions
(1)
SafeR mode
(3)
Inhibited: 6.0 µA
With pacing: 8.0 µA
Shipment conditions
(1)
DDD mode
Inhibited: 6.0 µA
100% pacing: 13.4 µA
Cenelec conditions
(2)
SafeR mode
(3)
Inhibited: 6.1 µA
With pacing: 7.8 µA
Cenelec conditions
(2)
DDD mode
Inhibited: 6.1 µA
100% pacing: 12.2 µA
(1) 60 ppm, 3.5 V, 0.35 ms, 500 Ω, Holter ON, sensors ON.
(2) 70 ppm, 2.5 V, 0.5 ms, 500 Ω, Holter ON, sensors ON.
(3) Twenty minutes after the detection of implantation, the device switches automatically from
DDD to SafeR mode, assuming 5% ventricular pacing and 50% atrial pacing.
For the SR model, the current drain at the beginning of service is as follows:
Shipment conditions
(1)
VVI mode
Inhibited: 5.8 µA
100% pacing: 10.1 µA
Cenelec conditions
(2)
VVI mode
Inhibited: 5.8 µA
100% pacing: 8.8 µA
(1) 70 ppm, 3.5 V, 0.35 ms, 500 Ω, Holter ON, sensors ON.
(2) 70 ppm, 2.5 V, 0.5 ms, 500 Ω, Holter ON, sensors ON.
20.1.
20. ELECTRICAL CHARACTERISTICS
66 ALIZEA – UA10414A